Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 16/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3697253 | 0.87 | MTNR1A (0.45) | KCNH2MTNR1AMTNR1B | |
| SCHEMBL3686473 | 0.84 | KCNH2 (0.49) | KCNH2MTNR1AMTNR1B | |
| SCHEMBL3688396 | 0.82 | KCNH2 (0.74) | KCNH2 | |
| SCHEMBL3699153 | 0.79 | KCNH2 (0.44) | KCNH2MTNR1AMTNR1B | |
| SCHEMBL3699150 | 0.79 | KCNH2 (0.44) | KCNH2MTNR1AMTNR1B | |
| SCHEMBL5648051 | 0.79 | KCNH2 (0.55) | KCNH2MTNR1AMTNR1B | |
| SCHEMBL3687390 | 0.78 | KCNH2 (0.74) | KCNH2 | |
| SCHEMBL3688159 | 0.78 | KCNH2 (0.74) | KCNH2 | |
| SCHEMBL3688156 | 0.78 | KCNH2 (0.74) | KCNH2 | |
| SCHEMBL3685555 | 0.77 | MTNR1A (0.46) | KCNH2MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0726357-A1 | Inhibiting anaerobic production of volatile fatty acids and hydrogen by bacteria | BETZ LABORATORIES INC. (US) | 1996-08-14 | — | — | EP | claimed |
| CN-110366428-B | Polypeptide-antigen conjugates with unnatural amino acids | VAXCYTE公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-1711056-B1 | ANTIMICROBIAL COMPOSITIONS COMPRISING POLYMERIC STABILIZERS | BASF SE (DE) | 2010-11-10 | — | — | EP | disclosed |
| EP-2239260-A1 | Novel compounds with antibacterial activity | Morphochem Aktiengesellschaft Für Kombinatorische Chemie (DE) | 2010-10-13 | — | — | EP | disclosed |
| US-7479476-B2 | Antimicrobial compositions comprising polymeric stabilizers | BASF AKTIENGESELLSCHAFT (DE) | 2009-01-20 | — | — | US | disclosed |
| US-7223776-B2 | Compounds with anti-bacterial activity | MORPHOCHEM AG (DE) | 2007-05-29 | — | — | US | disclosed |
| US-7223776-B2 | Compounds with anti-bacterial activity | MORPHOCHEM AG (DE) | 2007-05-29 | — | — | US | disclosed |
| US-7223776-B2 | Compounds with anti-bacterial activity | MORPHOCHEM AG (DE) | 2007-05-29 | — | — | US | disclosed |
| US-20070111915-A1 | Antimicrobial compositions comprising polymeric stabilizers | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-17 | — | — | US | disclosed |
| EP-1711056-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING POLYMERIC STABILIZERS | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-18 | — | — | EP | disclosed |
| EP-1349457-B1 | LIQUID ANTIMICROBIAL COMPOSITIONS | BASF AG (DE) | 2006-07-26 | — | — | EP | disclosed |
| US-20060040949-A1 | Novel compounds with antibacterial activity | MORPHOCHEM AG | 2006-02-23 | — | — | US | disclosed |
| WO-2005053398-A1 | ANTIMICROBIAL COMPOSITIONS COMPRISING POLYMERIC STABILIZERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-16 | — | — | WO | disclosed |
| US-6866869-B2 | Liquid antimicrobial compositions | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-15 | — | — | US | disclosed |
| US-20040052778-A1 | Liquid antimicrobial compositions | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-18 | — | — | US | disclosed |
| EP-1349457-A1 | LIQUID ANTIMICROBIAL COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002054872-A1 | LIQUID ANTIMICROBIAL COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-18 | — | — | WO | disclosed |
| EP-0726357-A1 | Inhibiting anaerobic production of volatile fatty acids and hydrogen by bacteria | BETZ LABORATORIES INC. (US) | 1996-08-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060040949-A1 | Novel compounds with antibacterial activity | MRPL21, Q6ZSR9, MRPL19 | KCNH2 2411/4885MTNR1A 3313/4885MTNR1B 2889/4885 |
| US-20040052778-A1 | Liquid antimicrobial compositions | LPO, MPO, GPX1 | KCNH2 475/4885MTNR1A 3922/4885MTNR1B 3915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.